搜索临床试验以:ARQ 197
总计7701个结果
-
Amgen终止MUC17阳性实体瘤美国, 大韩民国, 台湾, 西班牙, 奥地利, 法国, 日本, 德国, 荷兰
-
Radboud University Medical CenterDutch Cancer Society完全的
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA); University of Washington; Seattle Children's Hospital; University... 和其他合作者完全的
-
Magenta Therapeutics, Inc.终止
-
Region ÖstergötlandLinkoeping University; Örebro University, Sweden主动,不招人
-
Elizabeth J FranzmannAveta Biomics, Inc.招聘中
-
Taiho Oncology, Inc.终止
-
National Cancer Institute (NCI)主动,不招人
-
Sunnybrook Health Sciences CentreThe Physicians' Services Incorporated Foundation; Canadian Anesthesiologists' Society完全的
-
GE HealthcareQuintiles, Inc.; Covance; ABX CRO; Examination Management Services Inc.; Averion International Corporation终止
-
Arvinas Inc.招聘中复发/难治性 (R/R) 成熟 B 细胞非霍奇金淋巴瘤 (NHL) | 复发/难治性 (R/R) 血管免疫母细胞 T 细胞淋巴瘤 (AITL)美国, 西班牙
-
PfizerArvinas Estrogen Receptor, Inc.主动,不招人
-
Amgen招聘中
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford University招聘中
-
Prof JMA LangeEuropean and Developing Countries Clinical Trials Partnership (EDCTP)终止
-
Vertex Pharmaceuticals Incorporated完全的
-
Idience Co., Ltd.National OncoVenture; IlDong Pharmaceutical Co Ltd完全的
-
Merck Sharp & Dohme LLC终止